Literature DB >> 9325391

PACAP38 modulates activity of NMDA receptors in cultured chick cortical neurons.

G J Liu1, B W Madsen.   

Abstract

The outside-out recording mode of the patch-clamp technique was used to study modulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP38) on N-methyl--aspartate (NMDA) receptor activity in cultured chick cortical neurons. Biphasic concentration-dependent effects of PACAP38 on channel opening frequency induced by NMDA (20 microM) and glycine (1 microM) were found, with low concentrations (0.5-2 nM) of PACAP38 increasing activity and higher concentrations (10-1,000 nM) causing inhibition. These effects were reversible, reduced with higher concentrations of glycine (2-10 microM) but not by 200 microM NMDA, and inhibited by 10 microM 7-chlorokynurenic acid. In addition, 1 microM PACAP6-38 (a PACAP antagonist) inhibited channel activity due to 20 microM NMDA and 1 microM glycine by 66%, and this inhibition was reduced to 13% in the additional presence of 2 nM PACAP38. These observations suggest that PACAP38 has a direct modulatory effect on the NMDA receptor that is independent of intracellular second messengers and probably mediated through the glycine coagonist site(s).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325391     DOI: 10.1152/jn.1997.78.4.2231

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  11 in total

1.  Effects of intrathecal administration of pituitary adenylate cyclase activating polypeptide on lower urinary tract functions in rats with intact or transected spinal cords.

Authors:  Mitsuharu Yoshiyama; William C de Groat
Journal:  Exp Neurol       Date:  2008-03-07       Impact factor: 5.330

2.  Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.

Authors:  S F Traynelis; M F Burgess; F Zheng; P Lyuboslavsky; J L Powers
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism.

Authors:  M Figiel; J Engele
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse.

Authors:  Kimi Endo; Tomoya Nakamachi; Tamotsu Seki; Nobuyuki Kagami; Yoshihiro Wada; Keisuke Nakamura; Koji Kishimoto; Motohide Hori; Daisuke Tsuchikawa; Norihito Shinntani; Hitoshi Hashimoto; Akemichi Baba; Ryohei Koide; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2010-08-12       Impact factor: 3.444

Review 5.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region.

Authors:  M Roberto; M Brunelli
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

7.  Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light.

Authors:  M E Harrington; S Hoque; A Hall; D Golombek; S Biello
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

8.  Differential effects of PACAP-38 on synaptic responses in rat hippocampal CA1 region.

Authors:  M Roberto; R Scuri; M Brunelli
Journal:  Learn Mem       Date:  2001 Sep-Oct       Impact factor: 2.460

9.  The involvement of PACAP/VIP system in the synaptic transmission in the hippocampus.

Authors:  Kai Yang; Gang Lei; Michael F Jackson; John F Macdonald
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

Review 10.  The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide in the neural pathways controlling the lower urinary tract.

Authors:  Mitsuharu Yoshiyama; William C de Groat
Journal:  J Mol Neurosci       Date:  2008-08-02       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.